Sabra Health Care REIT, Inc (SBRA)

Sabra Health Care REIT, Inc. (“Sabra”, the “Company”) (Nasdaq: SBRA) announced that Sabra, pursuant to its joint venture with Sienna Senior Living (“Sienna”) (TSX: SIA), has completed the previously announced acquisition of a high-quality Canadian senior housing portfolio for a total consideration of C$307.5 million (USD $236.5 million).

MARKHAM, Ontario, May 17, 2022 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE.TO) announced today that, effective May 16, 2022, it has completed the previously announced sale of its retirement living operations comprised of 1,048 retirement living suites across 11 retirement communities (the “Portfolio”), located in Ontario and Saskatchewan, to Sienna-Sabra LP, a partnership formed between Sienna Senior Living Inc. (TSX: SIA.TO) and SABRA Healthcare REIT (NASDAQ:

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Vanguard Real Estate ETF (VNQ), we found that the implied analyst target price for the ETF based upon its underlying holdings is $116.30 per unit.

These income stocks, with yields ranging from 7.3% to 11.6%, can make long-term investors a lot richer.

Sabra (SBRA) delivered FFO and revenue surprises of 2.63% and 1.15%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the first quarter of 2022. In addition, the Company provided a business update.

Easterly Government Properties (DEA) delivered FFO and revenue surprises of -2.94% and 3.29%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

These supercharged income stocks sport an average yield of 10.73%!

Investors in Sabra Health Care REIT Inc (SBRA) saw new options begin trading this week, for the June 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the SBRA options chain for the new June 17th contracts and identified one put and one call contract of particular interest.

Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Fitch Ratings has affirmed the ratings for Sabra and its subsidiaries at 'BBB-'; Fitch’s Rating Outlook of Stable also remains unchanged.

Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that it will issue its 2022 first quarter earnings release on May 4, 2022 after the close of trading.

Sabra Health Care REIT, Inc. (“Sabra”) (Nasdaq: SBRA) today announced it has joined the Well Living Lab, founded as a Delos and Mayo Clinic collaboration, as an Alliance Member and active participant in Delos’ WISE – Wellness Innovation in Senior Environments – initiative.

On Tuesday, 242 companies hit new 52-week lows. Noteworthy Mentions In Today's 52-Week Lows: The largest company ...

Upgrades For PBF Energy Inc (NYSE:PBF), Scotiabank upgraded the previous rating of Sector Underperform to Sector Perform. For the ...

If you want to know who really controls Sabra Health Care REIT, Inc. ( NASDAQ:SBRA ), then you'll have to look at the...

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Invesco S&P MidCap 400— Pure Value ETF (RFV), we found that the implied analyst target price for the ETF based upon its underlying holdings is $108.40 per unit.

These income stocks, with yields ranging from 7.2% to 8.4%, are perfectly positioned to make patient investors a lot richer.

There's one sector of the REIT universe that continues to be down and out: nursing homes. Is it worth jumping in?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips It's just as important to know what dividend stocks to avoid as it is to know which ones to buy, especially in the current market. The post 7 Dividend Stocks to Avoid in the Rotation to Safety appeared first on InvestorPlace. More From InvestorPlace Get in Now on Tiny $3 ‘Forever Battery’ Stock It doesn’t matter if you have $500 in savings or $5 million. Do this now. Stock Prodigy Who Found NIO at $2… Says Buy THIS Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”

Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company’s Chair and Chief Executive Officer, Talya Nevo-Hacohen, the company’s Chief Investment Officer, Jessica Flores, the company’s Senior Vice President of Finance and Controller, and Lukas Hartwich, the company’s Senior Vice President of Finance, will participate in the Credit Suisse Inaugural Healthcare REIT Summit April 5, 2022 at the Credit Suisse Office in New York, New York.

A more than 20% decline in the Nasdaq is your open invitation to buy these income stocks, which are yielding between 4% and 11.2%.

The bullseye became a Divided King last year.

In this article, we discuss 10 dividend stocks Redditors buy for early retirement. If you want to skip our detailed analysis of these stocks, go directly to 5 Dividend Stocks Redditors Buy for Early Retirement. With the outcome of the Russia-Ukraine war looking uncertain at the moment, the stock market is quite turbulent. In addition […]

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the First Trust Horizon Managed Volatility Small/Mid ETF (HSMV), we found that the implied analyst target price for the ETF based upon its underlying holdings is $38.56 per unit.

Upgrades According to B of A Securities, the prior rating for Sabra Health Care REIT Inc (NASDAQ:SBRA) was changed from Underperform to ...

Announcement of Periodic Review: Moody's announces completion of a periodic review for a group of REITs Healthcare issuersGlobal Credit Research - 10 Mar 2022New York, March 10, 2022 -- Moody's Investors Service (“Moody's”) has completed a periodic review of the ratings -and other ratings that are associated with the same analytical units for the rated entity(entities) listed below.The review was conducted through a portfolio review discussion held on 3 March 2022 in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers. A possible outcome from periodic reviews is a referral of a rating to a rating committee.This publication does not announce a credit rating action and is not an indication of whether or not a credit rating action is likely in the near future.

Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Talya Nevo-Hacohen, the company’s Chief Investment Officer, Darrin Smith, the company’s Executive Vice President of Investments, and other members of the company will participate in the 2022 NIC Spring Conference March 23 - 25, 2022 at the Omni Dallas Hotel in Dallas, Texas.

According to select analysts, these income stocks, with yields of 8.7% and 8.9%, could soar.

These income stocks, with yields ranging from 7% to 11.2%, can put inflation in its place.

Sabra (SBRA) delivered FFO and revenue surprises of 2.78% and 11.73%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?